BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2454615)

  • 1. [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].
    Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Tamura K; Hokama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1901-8. PubMed ID: 2454615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefit of cisplatin-based polychemotherapy for adenocarcinoma of the lung. The Kyushu Lung Cancer Chemotherapy Study Group.
    Hara N; Ohta M; Ichikawa Y; Kanda T; Shima K; Tamura K; Hokama M
    Cancer Chemother Pharmacol; 1990; 26(1):47-51. PubMed ID: 2108816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination chemotherapy for bronchogenic carcinoma based on cell type].
    Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Hokama M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):86-94. PubMed ID: 2417564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A randomized trial with various combinations of cis-platinum (CDDP), mitomycin C (MMC), peplomycin (PEP) and ftorafur (FT) in the treatment of non-small cell lung cancer].
    Nakabayashi T; Yasuda S; Miyamoto H; Abe S; Ohosaki Y
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2998-3004. PubMed ID: 2429619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
    Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
    Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CDDP-containing combination chemotherapy for advanced lung cancer].
    Asamoto H; Hisa T; Sawano T; Sakai K; Kitamura S; Matsushita N; Kokura M; Satake H; Kawakami I
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2544-9. PubMed ID: 6210053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
    Sculier JP; Lafitte JJ; Paesmans M; Thiriaux J; Alexopoulos CG; Baumöhl J; Schmerber J; Koumakis G; Florin MC; Zacharias C; Berghmans T; Mommen P; Ninane V; Klastersky J
    Br J Cancer; 2000 Nov; 83(9):1128-35. PubMed ID: 11027424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination chemotherapy consisting of cis-platinum and adriamycin in non-small cell carcinoma of the lung].
    Fujii M; Okabe K; Ishikawa M; Toki H; Fujita Y; Araki Y
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):265-9. PubMed ID: 6198968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
    Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status in the treatment of inoperable non-small cell lung cancer (NSCLC)].
    Nishimura M; Sugiura T; Urata A; Ota K
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):54-60. PubMed ID: 2578274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MEP therapy of advanced lung cancer].
    Komuro Y; Ohnishi M; Saitoh A; Morohashi Y
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2688-91. PubMed ID: 2820313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adriamycin, cisplatin and etoposide combination chemotherapy in non-small cell lung cancer].
    Yamaji Y; Fujita J; Kamei M; Futami H; Hashimoto Y; Bungo M; Nakamura H; Hata Y; Shiotani T; Irino S
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):601-6. PubMed ID: 1849390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
    Joss RA; Alberto P; Obrecht JP; Barrelet L; Holdener EE; Siegenthaler P; Goldhirsch A; Mermillod B; Cavalli F
    Cancer Treat Rep; 1984 Sep; 68(9):1079-84. PubMed ID: 6090014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
    Waller D; Peake MD; Stephens RJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):173-82. PubMed ID: 15200998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
    Fujii M; Kiura K; Okabe K; Toki H; Kimura M
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
    Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of large cell carcinoma of the lung responding to cisplatin-based polychemotherapy].
    Kajiki A; Tsuda T; Tazaki H; Yamazaki H; Miyazaki N; Kido M; Kuroiwa A
    Gan No Rinsho; 1988 Jan; 34(1):63-6. PubMed ID: 2448504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multidisciplinary treatment for small cell lung cancer].
    Saijo N; Eguchi K; Shimizu E; Shinkai T; Tominaga K; Takahashi K; Sasaki Y; Seki S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):474-9. PubMed ID: 6322700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.